Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT06212505
Eligibility Criteria:
Inclusion Criteria:
* Male patients,
* Age \> 18 years at time of inclusion
* Diagnosis of severe hemophilia A (FVIII \<2%)
* Severe hemophilia A (FVIII \<2%) and not receiving emicizumab prophylaxis
* Obtaining the patient's non-opposition
* Ability to comply with the study protocol, in the investigator's judgment
Exclusion Criteria:
* Not willing to provide extra blood for the experiments
* Patients carrying the diagnoses of other coagulopathies in addition to hemophilia A
* Patients that have received any hemostatic agent within 5 half-lives of the blood draw.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT06212505
Study Brief:
Protocol Section:
NCT06212505